Search results
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 3 hours agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19vaccine for the 2024-2025 fall season...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 2 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 7 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 7 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 6 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 6 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 6 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 7 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...